Clinical Trials
Novartis launches first-of-its-kind not-for-profit portfolio of medicines for symptomatic treatment of COVID-19
Novartis announced a new initiative to help patients in low-income and lower-middle-income countries (LIC; LMIC) access affordable medicines to treat the major symptoms of COVID-19...
Clinical Trials
Biogen Plans to Initiate Phase 4 Study Evaluating Benefit of SPINRAZA in Patients Treated with Zolgensma
Biogen Inc announced it plans to initiate a global Phase 4 clinical study, RESPOND, to examine the clinical benefit and assess the safety of SPINRAZA®...
Clinical Trials
Oxford COVID-19 Vaccine Shows Promise In Early Testing: Study
An experimental COVID-19 vaccine, being developed by the University of Oxford, was safe and produced an immune response in early-stage clinical trials in healthy volunteers,...
Clinical Trials
Moderna’s COVID-19 Vaccine Soon to Enter Phase 3 Trials as Phase 1 Shows Positive Results
Moderna, an American biotech company announced on July 14 that its COVID-19 vaccine candidate is finally going to enter the final phase on July 27...
Clinical Trials
ACTC, Eisai & Biogen announce initiation of new phase III clinical study of BAN2401 for preclinical Alzheimer’s disease
The Alzheimer's Clinical Trials Consortium , Eisai Co., Ltd and Biogen Inc announced that a new phase III clinical study (AHEAD 3-45) of BAN2401, an...
Clinical Trials
Orgenesis to Collaborate with Educell to Conduct Clinical Validation of Cell Therapies
Orgenesis Inc., a pioneering global biotech company committed to accelerating commercialization and transforming the delivery of cell and gene therapies (CGTs), announces that it has...
Clinical Trials
Byondis Investigational Antibody-Drug Conjugate SYD985 Selected for I-SPY 2 TRIAL in Early-Stage Breast Cancer
Byondis B.V. announced that Quantum Leap Healthcare Collaborative selected the company’s investigational antibody-drug conjugate (ADC) SYD985 (trastuzumab duocarmazine) for a new investigational treatment arm in...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.